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Abstract: Both choroidal neovascularization during pregnancy, and choroidal neovascularization following implantation 
of phakic intraocular lenses have been reported in the literature. To our knowledge, this is the first case reported of a 
gravid woman developing choroidal neovascularization in an eye with a phakic intraocular lens. A 31-year-old woman 
became aware of her pregnancy three weeks after placement of the Verisyse™ iris-supported phakic intraocular lens. She 
was at 15 weeks gestation when she developed a Fuch’s spot consistent with choroidal neovascularization. By eight 
months gestation, her symptoms nearly resolved. While the development of choroidal neovascularization in this patient 
may appear incidental, women of childbearing age considering phakic intraocular lenses warrant additional discussion on 
the possible increased likelihood of choroidal neovascularization. 
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INTRODUCTION 
  It has long been known that pregnancy has an impact on 
various diseases including hypertension, diabetes, and graves 
disease. It can also precipitate disease, as in pregnancy-
induced-hypertension and gestational diabetes. Very little 
has been written concerning choroidal neovascularization 
(CNV) in pregnancy. One case report describes CNV as a 
complication of pre-eclampsia in a patient with 
antiphospholipid syndrome [1].
 Another publication looked 
at the association between development of CNV and 
pregnancy [2].
  There have also been case reports of CNV 
occurring in myopes receiving phakic intraocular lenses [3-
6]. To our knowledge, no cases have reported CNV in a 
pregnant patient with the Verisyse™ (Abbott Medical Optics 
Inc. Abbott, IL, USA) iris-supported phakic intraocular lens 
(IOL). While no current evidence exists showing a 
correlation, such an association would have an impact on 
advising women of childbearing age considering anterior 
chamber intraocular lenses for vision correction. 
CASE REPORT 
  A 39-year-old woman with a manifest refraction (MR) of 
-14.25+1.50x53º, and a corrected distance visual acuity 
(CDVA) of 20/20 OS, underwent surgery with placement of 
a  -14.00 diopter iris-supported phakic IOLs (Verisyse™) 
without knowing she was pregnant. Resultant uncorrected 
distance visual acuity (UDVA) was 20/30. Three weeks after 
Verisyse™ implantation she became aware of her pregnancy 
and was determined to be at 15 weeks gestation. At this time, 
she developed acute vision loss in the left eye. She reported 
seeing a dark blue/brown circle in her central vision, and 
blurriness without pain. The patient denied trauma or flashes 
of light. Her only medications were a daily prenatal vitamin  
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and artificial tears as needed. On examination her CDVA 
was 20/60 OS with mild metamorphopsia. Anterior segment 
exam showed a well-positioned Verisyse™ lens. 
Fundoscopic exam of the left eye revealed a small area of 
hemorrhage directly in the fovea, consistent with a Fuch’s 
spot (Fig. 1).  Stratus optical coherence tomography (Carl 
Zeiss Meditec, Dublin, CA) demonstrated findings consistent 
with CNV (Fig. 2). She had a normal optic disc size, shape, 
and color, with sharp margins and a cup-to-disc ratio of 0.2. 
The major retinal vasculature appeared to be normal. In the 
foveal region, pigmentary mottling and some intraretinal 
hemorrhage extended temporal to the fovea. Fluorescein 
angiography and visudyne photodynamic treatment were not 
done due to the pregnancy. The plan was observation and to 
return if vision worsened.  Her vision stabilized one month 
later, and UDVA remained 20/60. Two months after her 
onset of symptoms (23 weeks gestation), UDVA improved 
to 20/40 with less distortion and blurriness. Dilated fundus 
exam showed subtle hemorrhages just temporal to the fovea.  
  There was concern that valsalva manouvres during 
vaginal delivery might lead to increased retinal bleeding, 
therefore, cesarean section was performed at term. By phone 
interview one week after delivery, she reported her vision 
was near baseline and there was only slight distortion on 
using Amsler grid. 
DISCUSSION 
  Choroidal neovascularization following correction of 
high myopia with phakic intraocular lenses has been reported 
to develop in 1.70% to 2.38% of patients [3, 5, 6]. Time to 
development of CNV from implantation has been reported to 
range from 1-87 months with an average time of 33 months 
[6]. Choroidal neovascularization in pregnancy has also been 
reported to develop around the 6
th month of pregnancy [1, 2]. 
To our knowledge, this is the first report of CNV developing 
in a gravid patient with an anterior chamber phakic 
intraocular lens. Current guidelines recommend against 
implantation of the Verisyse™ lens if a woman is pregnant 18    The Open Ophthalmology Journal, 2012, Volume 6   et al. 
or nursing [7]. Complications from surgery may require 
medications that can cross the placenta and affect the fetus, 
or be transmitted through breast milk to the infant. 
 
Fig. (1). Color fundus photograph and red free fundus photograph 
(insert) of the left eye taken at 15 weeks pregnant showing a Fuch’s 
spot with hemorrhage (arrows) over the fovea. 
 
Fig. (2). Optical coherence tomography of the left eye 
demonstrating a subfoveal lesion consistent with CNV. 
  Other than being highly myopic, our patient had no other 
known risk factors to explain the development of CNV 
during her pregnancy. The phakic lens, pregnancy, high 
myopia, undiagnosed lacquer cracks, or a combination of 
these may have caused the CNV. Further research is needed 
to help elucidate these complex relationships. We are 
reporting this case in an attempt to alert the surgeon of a 
potential increased risk of CNV, should a woman become 
pregnant after receiving a phakic anterior chamber lens.  
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